AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

SUMATRIPTAN

4 registrations across 4 African markets— 3 active

Markets with SUMATRIPTAN

🇲🇦Morocco
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active
🇿🇦South Africa
1 registration
0 active
🇿🇼Zimbabwe
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
SUMASON-50
TABLET, COATED; ORAL
🇿🇼ZimbabwePHARMACEUTICAL AND CHEMICAL DISTRIBUTORS PRIVATE LTDactiveDec 2027
IMIGRAN 20 mg NASAL SPRAY🇿🇦South AfricaGlaxoSmithKline South Africa (Pty) LimitedsuspendedJul 2023
IMIGRAN
COMPRIME PELLICULE
🇲🇦Morocco—active—
Sumafix 100
Tablets
🇹🇿TanzaniaAurobindo Pharma Limitedactive—

SUMATRIPTAN in Africa — Regulatory Overview

SUMATRIPTAN is registered across 4 African markets with 4 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Morocco, Tanzania, South Africa, Zimbabwe. AfricaRegulatory refreshes this data daily from official government sources.

Of the 4 registrations, 3 (75%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.